Why the study?
Aerobic interval training attenuates cardiovascular disease risk and premature mortality, but rarely reaches patients, leaving its 1-year effects and feasibility with adherence support in schizophrenia outpatients unclear.
Does supervised aerobic interval training improve peak oxygen uptake in outpatients with schizophrenia?
Does supervised aerobic interval training improve peak oxygen uptake in outpatients with schizophrenia?
Supervised aerobic interval training over 1 year is feasible and significantly improves peak oxygen uptake in outpatients with schizophrenia, offering a strategy for cardiovascular disease risk reduction.
AIT feasible with adherence support in schizophrenia outpatients; leaves open effects on clinical outcomes pending larger trials.
Although aerobic interval training (AIT) is recognized to attenuate the risk of cardiovascular disease (CVD) and premature mortality, it appears that it rarely arrives at patients’ doorsteps. Thus, this study investigated 1‐year effects and feasibility of AIT delivered with adherence support in collaborative care of outpatients with schizophrenia. Forty‐eight outpatients (28 men, 35 [31‐38] (mean [95% confidence intervals]) years; 20 women, 36 [30‐41] years) with schizophrenia spectrum disorders (ICD‐10) were randomized to either a collaborative care group provided with municipal transportation service and training supervision (walking/running 4 × 4 minutes at ~90% of peak heart rate; HR peak ) 2 d wk −1 at the clinic (TG) or a control group (CG) given 2 introductory AIT sessions and advised to continue training. Directly assessed peak oxygen uptake ( ) increased in the TG after 3 months (2.3 [0.6‐4.4] mL kg −1 min −1 , Cohen's d = 0.33[−4.63 to 4.30], P = 0.04), 6 months (2.7 [0.5‐4.8] mL kg −1 min −1 , Cohen's d = 0.42[−4.73 to 4.11], P = 0.02) and 1 year (4.6 [2.3‐6.8] mL kg −1 min −1 , Cohen's d = 0.70[−4.31 to 4.10], P < 0.001) compared to the CG. One‐year cardiac effects revealed higher HR peak (7 [2‐11] b min −1 , Cohen's d = 0.34[−8.48 to 8.65], P = 0.01), while peak stroke volume tended to be higher (0.9 [−0.2 to 2.0] mL b −1 , Cohen's d = 0.35[−1.62 to 2.01], P = 0.11) in the TG compared to the CG. Conventional risk factors (body weight, waist circumference, blood pressure, and lipids/glucose) remained unaltered in both groups. One‐year AIT adherence rates were 15/25 (TG; different from CG: P < 0.001) and 0/23 (CG). AIT was successfully included in long‐term collaborative care of outpatients with schizophrenia and yielded improved , advocating this model for aerobic capacity improvement and CVD risk reduction in future treatment.
No takes yet. Share an insight, caveat, or question.
Brobakken et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: